Drug Profile
Research programme: topical therapeutics for pain and nasal congestion - China Pharmaceutical University/ Johnson and Johnson Innovation
Alternative Names: Nasal decongestants - China Pharmaceutical University, Johnson & Johnson Innovation; Pain therapeutics - China Pharmaceutical University, Johnson & Johnson InnovationLatest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator China Pharmaceutical University; Johnson & Johnson Innovation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Nasal congestion; Pain
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in Nasal congestion in China (Topical)
- 28 Nov 2018 No recent reports of development identified for research development in Pain in China (Topical)
- 29 Oct 2014 Early research in Nasal congestion and Pain in China (Topical)